Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger J Pomerantz

Showing results (31-40 of 85) with videos related to

Pageof 9
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|April 23, 2004
HIV-1-mediated apoptosis of neuronal cells: Proximal molecular mechanisms of HIV-1-induced encephalopathyYan Xu, Joseph Kulkosky, Edward Acheampong, et al.
Virus Research|November 6, 2007
Antiviral potentials of medicinal plantsMuhammad Mukhtar, Mohammad Arshad, Mahmood Ahmad, et al.
Journal of Virology|December 12, 2001
Rhabdovirus-based vectors with human immunodeficiency virus type 1 (HIV-1) envelopes display HIV-1-like tropism and target human dendritic cellsHeather D Foley, Miguel Otero, Jan M Orenstein, et al.
Virology|April 21, 2005
Inhibition of HIV-1 replication by caffeine and caffeine-related methylxanthinesGiuseppe Nunnari, Elias Argyris, Jianhua Fang, et al.
Current HIV Research|May 17, 2007
Effects of highly active antiretroviral therapy on HIV-1-associated oral complicationsZahida Parveen, Edward Acheampong, Roger J Pomerantz, et al.
AIDS Research and Human Retroviruses|June 10, 2004
Expression of latent HAART-persistent HIV type 1 induced by novel cellular activating agentsJoseph Kulkosky, Julie Sullivan, Yan Xu, et al.
Nature|June 17, 2003
The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNAHui Zhang, Bin Yang, Roger J Pomerantz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 12, 2002
Combination genetic therapy to inhibit HIV-1David S Strayer, Francisco Branco, Julien Landré, et al.
Current HIV Research|March 27, 2004
Recombinant rhabdoviruses as potential vaccines for HIV-1 and other diseasesPhilip M McKenna, James P McGettigan, Roger J Pomerantz, et al.
Journal of Virology|November 12, 2003
Covalently linked human immunodeficiency virus type 1 gp120/gp41 is stably anchored in rhabdovirus particles and exposes critical neutralizing epitopesPhilip M McKenna, Roger J Pomerantz, Bernhard Dietzschold, et al.
Pageof 9

Showing results (31-40 of 85) with videos related to

Sort By:
Pageof 9
Proceedings of the National Academy of Sciences of the United States of America|April 23, 2004
HIV-1-mediated apoptosis of neuronal cells: Proximal molecular mechanisms of HIV-1-induced encephalopathyYan Xu, Joseph Kulkosky, Edward Acheampong, et al.
Virus Research|November 6, 2007
Antiviral potentials of medicinal plantsMuhammad Mukhtar, Mohammad Arshad, Mahmood Ahmad, et al.
Journal of Virology|December 12, 2001
Rhabdovirus-based vectors with human immunodeficiency virus type 1 (HIV-1) envelopes display HIV-1-like tropism and target human dendritic cellsHeather D Foley, Miguel Otero, Jan M Orenstein, et al.
Virology|April 21, 2005
Inhibition of HIV-1 replication by caffeine and caffeine-related methylxanthinesGiuseppe Nunnari, Elias Argyris, Jianhua Fang, et al.
Current HIV Research|May 17, 2007
Effects of highly active antiretroviral therapy on HIV-1-associated oral complicationsZahida Parveen, Edward Acheampong, Roger J Pomerantz, et al.
AIDS Research and Human Retroviruses|June 10, 2004
Expression of latent HAART-persistent HIV type 1 induced by novel cellular activating agentsJoseph Kulkosky, Julie Sullivan, Yan Xu, et al.
Nature|June 17, 2003
The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNAHui Zhang, Bin Yang, Roger J Pomerantz, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 12, 2002
Combination genetic therapy to inhibit HIV-1David S Strayer, Francisco Branco, Julien Landré, et al.
Current HIV Research|March 27, 2004
Recombinant rhabdoviruses as potential vaccines for HIV-1 and other diseasesPhilip M McKenna, James P McGettigan, Roger J Pomerantz, et al.
Journal of Virology|November 12, 2003
Covalently linked human immunodeficiency virus type 1 gp120/gp41 is stably anchored in rhabdovirus particles and exposes critical neutralizing epitopesPhilip M McKenna, Roger J Pomerantz, Bernhard Dietzschold, et al.
Pageof 9